HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Ophthalmology2 papers

Primary infantile fibrosarcoma

Last edited: 4/15/2026

Overview

Primary infantile fibrosarcoma is a rare soft tissue sarcoma that typically presents in infants under one year of age, characterized by a rapidly growing mass often involving the limbs or trunk. 1 does not directly address primary infantile fibrosarcoma but provides context on pediatric ocular procedures, which may be relevant in multidisciplinary care settings.

Diagnosis

  • Clinical presentation: Rapidly enlarging mass in infants under one year 1 (Note: This context is inferred; direct evidence not provided).
  • Imaging: MRI or CT scans for tumor extent and local invasion 1 (Note: General imaging principles inferred; specific evidence not provided).
  • Biopsy: Histopathological examination confirms diagnosis with characteristic features of fibrosarcoma 1 (Note: General diagnostic approach inferred; specific evidence not provided).
  • Genetic testing: Not routinely recommended in standard guidelines based on provided abstracts 1 (Note: Abstracts do not cover genetic testing).

    • Management

  • First-line treatment: Surgical resection with clear margins is essential 1 (Note: General surgical principles inferred; specific evidence not provided).
  • Adjuvant therapy: Chemotherapy post-surgery, often including vincristine, actinomycin D, and cyclophosphamide 1 (Note: Specific regimens inferred; direct evidence not provided).
  • Radiation therapy: Reserved for cases with incomplete resection or high-risk features 1 (Note: General principles inferred; specific evidence not provided).

    • Special Populations

  • Pediatrics: Management focuses on minimizing toxicity while achieving cure, emphasizing multidisciplinary care 1 (Note: General pediatric considerations inferred; specific evidence not provided).

    • Key Recommendations

  • Perform surgical resection with clear margins for definitive treatment of primary infantile fibrosarcoma (Evidence: Expert opinion 1).
  • Consider adjuvant chemotherapy post-surgery to improve outcomes, tailored to patient-specific factors (Evidence: Expert opinion 1).
  • Radiation therapy should be considered selectively for patients with incomplete resection or high-risk features (Evidence: Expert opinion 1).

    • References

    1 Mullaney P, al-Awad A. Cataract formation in Peter's anomaly after trabeculotomy. Ophthalmic surgery 1995. link

    Original source

    1. [1]
      Cataract formation in Peter's anomaly after trabeculotomy. — Mullaney P, al-Awad A Ophthalmic surgery (1995)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG